Background Research is urgently needed to reduce the morbidity and mortality of Lassa
fever (LF), including clinical trials to test new therapies and to verify the efficacy and safety of …

Hemorrhagic fevers (HF) resulting from pathogenic arenaviral infections have traditionally
been neglected as tropical diseases primarily affecting African and South American regions …

Lassa fever is a severe viral hemorrhagic fever caused by a zoonotic virus that repeatedly
spills over to humans from its rodent reservoirs. It is currently not known how climate and …

Lassa virus (LASV) is the etiologic agent of Lassa Fever, a hemorrhagic disease that is
endemic to West Africa. During LASV infection, LASV glycoprotein (GP) engages with …

Lassa fever (LF) is a deadly viral hemorrhagic disease that is endemic to West Africa. The
causative agent of LF is Lassa virus (LASV), which causes approximately 300,000 infections …

Lassa fever is an acute viral haemorrhagic illness caused by Lassa virus (LASV), which is
endemic throughout much of West Africa. The virus primarily circulates in the Mastomys …

Abstract Lassa fever hits West African countries annually in the absence of licensed vaccine
to limit the burden of this viral hemorrhagic fever. We previously developed MeV-NP, a …

The limited treatment options for the increasing occurrence of Lassa hemorrhagic fever in
West Africa poses an urgent need for the discovery and development of novel therapeutics …

Accurate data on the Lassa virus (LASV) human case fatality rate (CFR) and the prevalence
of LASV in humans, rodents and other mammals are needed for better planning of actions …

We phylogenetically compared sequences of the zoonotic Lassa virus (LASV) obtained from
Mastomys rodents in seven localities across the highly endemic Edo and Ondo States within …